Arcadia Biosciences (NASDAQ:RKDA) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a research note released on Thursday morning. The firm issued a sell rating on the basic materials company’s stock.

Arcadia Biosciences Trading Up 1.3 %

NASDAQ:RKDA opened at $3.91 on Thursday. The stock has a 50 day moving average of $5.05 and a two-hundred day moving average of $4.05. Arcadia Biosciences has a 12 month low of $1.85 and a 12 month high of $10.31. The firm has a market cap of $5.34 million, a P/E ratio of -0.91 and a beta of 0.88.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Arcadia Biosciences stock. Geode Capital Management LLC bought a new stake in Arcadia Biosciences, Inc. (NASDAQ:RKDA) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned about 0.90% of Arcadia Biosciences as of its most recent SEC filing. 17.73% of the stock is owned by institutional investors and hedge funds.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.